spironolactone/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Treatment with spironolactone was associated with a significant reduction in all-cause mortality [OR=0.4, 95%CI (0.24, 0.66), P=0.0003].”
Quoted verbatim from Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis.. - Study
- meta-analysis
- Population
- Adult patients with end-stage renal disease on hemodialysis, low-dose spironolactone added to conventional treatment versus control, pooled from randomised and non-randomised trials
Effect 0.4 odds ratio, 95% CI 0.24 to 0.66
Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis.2019PMID:31118582Permalink
Keep reading
- Everything the graph holds on spironolactone
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45C8R8RAW5AN61W5G4Z3H93